EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Urolithin A: A Novel Postbiotic for inflammation, aging, and cancer: A Journey from Dietary ellagitannins to clinical use

Saniya Thakur, M V N L Chaitanya, Sachin Kumar Singh, Navneet Khurana, Jubie Selvaraj, Arya Lakshmi M, Avijit Mazumder, Pallav Sengupta

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-11950-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 12.05.2026. Verfasst von Saniya Thakur und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical sciences, Lovely Professional university, Jalandhar - Delhi, Grand Trunk Rd, Phagwara, 144411, Punjab, India. Hauptthemen laut MEDLINE: Coumarins, Inflammation, Aging, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Urolithin A (UA) is synthesized when the body metabolizes ellagic acid and ellagitannins. UA has been a widely recognized physiologically active compound throughout the previous decade. The gut microbiota affects metabolic regulators AMPK and sirtuins, initiates autophagy, and activates mitochondrial quality control, which is essential for infection resistance, intestinal health, and inflammation reduction. METHODS: A preclinical study indicates that UA alters cancer cell metabolism, fortifies the intestinal barrier, safeguards the brain, and supports skeletal muscle health. UA enhances muscle endurance, mitochondrial function indicators, and cardiometabolic health without side effects or adverse reactions in preliminary human trials, primarily including the elderly and sedentary individuals. UA production exhibits significant variability due to the heterogeneity of gut flora. The existing classifications of A, B, and O kinds, absence of longitudinal data, limited trial sizes, and inconsistency between results and real-world outcomes impede the pharmaceutical advancement of UA. RESULTS: This review commenced with an examination of UA's origins, chemical properties, gastrointestinal metabolism, absorption, molecular functions, and therapeutic potential. The literature's validity, applicability, and knowledge gaps indicate that UA is a postbiotic treatment that influences the gut microbiome's impact on mitochondrial pathways affecting various bodily systems, considering the intricate connections among inflammation, aging, and cancer. Comprehensive clinical trials are required to validate the optimal composition, dosage, and therapeutic efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoumarinsInflammationAgingNeoplasmsHydrolyzable TanninsHumansAnimalsGastrointestinal Microbiome

Stichwörter der Autor:innen

EllagitanninsGut microbiomeInflammationMitochondriaMitophagyPostbioticUrolithin A

Substanzen

3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneCoumarinsHydrolyzable Tannins

Autor:innen und Institutionen

  • School of Pharmaceutical sciences, Lovely Professional university, Jalandhar - Delhi, Grand Trunk Rd, Phagwara, 144411, Punjab, India.
  • School of Pharmaceutical sciences, Lovely Professional university, Jalandhar - Delhi, Grand Trunk Rd, Phagwara, 144411, Punjab, India. mvnlcdiamond@gmail.com.
  • Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, 643001, Tamilnadu, India.
  • Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical sciences, Govt. of NCT of Delhi, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, New Delhi, 110017, India.
  • Noida institute of engineering and technology (Pharmacy Institute), Institutional Area, 19 knowledge Park II, Greater Noida, 201306, India.
  • Department of Biomedical Sciences, College of Medicine, Gulf Medical University, Ajman, UAE.

Zitieren

APA

Thakur, S., Chaitanya, M. V. N. L., Singh, S. K., Khurana, N., Selvaraj, J., M, A. L., Mazumder, A., & Sengupta, P. (2026). Urolithin A: A Novel Postbiotic for inflammation, aging, and cancer: A Journey from Dietary ellagitannins to clinical use. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-11950-4

Vancouver

Thakur S, Chaitanya MVNL, Singh SK, Khurana N, Selvaraj J, M AL, et al. Urolithin A: A Novel Postbiotic for inflammation, aging, and cancer: A Journey from Dietary ellagitannins to clinical use. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-11950-4

BibTeX
@article{Thakur2026,
  author = {Thakur, Saniya and Chaitanya, M V N L and Singh, Sachin Kumar and Khurana, Navneet and Selvaraj, Jubie and M, Arya Lakshmi and Mazumder, Avijit and Sengupta, Pallav},
  title = {Urolithin A: A Novel Postbiotic for inflammation, aging, and cancer: A Journey from Dietary ellagitannins to clinical use},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-11950-4}
}
Kostenlos starten →